 The study will be placed in 6 rheumatology clinics in Switzerland and in 4 travel medicine clinics. Consecutive subjects with rheumatoid arthritis, spondylarthritis ankylosing spondylitis, vasculitis ANCA associated vasculitis and Behçets disease and healthy controls will be recruited. 